Corpus Intelligence IC Memo — RED RIVER HOSPITAL 2026-04-26 09:55 UTC
IC Memo — RED RIVER HOSPITAL
Investment Committee Memorandum | TX | 96 beds | Grade C | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

RED RIVER HOSPITAL

CCN 454018 | WICHITA, TX | 96 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

RED RIVER HOSPITAL is a 96-bed suburban community hospital in WICHITA, TX with $21.4M in net patient revenue and a 9.1% operating margin. The hospital serves a payer mix of 7.8% Medicare, 0.5% Medicaid, and 91.6% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.1% to 16.4% (+736bps).

Net Revenue HCRIS$21.4M
Current EBITDA COMPUTED$1.9M
Operating Margin COMPUTED9.1%
Occupancy HCRIS77.4%
Revenue / Bed COMPUTED$223K
Net-to-Gross HCRIS36.3%
Distress Probability ML42.2%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
196
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 9.1% places it above the state median. Among 196 size-comparable peers (48-192 beds), the median margin is 2.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (48-192), prioritizing same-state peers. 196 hospitals in the comp set.

HospitalStateBedsRevenueMargin
RED RIVER HOSPITAL (Target)TX96$21.4M9.1%
ROUND ROCK HOSPITALTX165$681.4M8.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COVENANT CHILDRENS HOSPITALTX181$410.3M15.5%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
CHILDRENS HOSPITAL OF SAN ANTOTX174$376.5M-2.8%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
MEDICAL CITY MCKINNEYTX166$302.5M-0.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$449K+210bp18mo
Cost to Collect4.5%2.5%$428K+200bp12mo
Denial Rate Reduction12.0%6.5%$423K+198bp12mo
A/R Days Reduction5200.0%3800.0%$260K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$449K
Cost to Collect
$428K
Denial Rate Reduction
$423K
A/R Days Reduction
$260K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$1.9M
+ RCM Uplift+$1.6M
Pro Forma EBITDA$3.5M
Current Margin9.1%
Pro Forma Margin16.4%
WC Released (1x)$820K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.0M$28.5M9.56x57.1%
Base (11x exit)10.0x11.0x$3.0M$32.3M10.84x61.1%
Bull Case9.0x11.0x$2.7M$38.5M14.34x70.3%
Bull (12x exit)9.0x12.0x$2.7M$42.8M15.94x74.0%
Bear Case11.0x10.0x$3.3M$19.7M6.00x43.1%
Bear (11x exit)11.0x11.0x$3.3M$22.7M6.93x47.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 196 hospitals with 48-192 beds
  • Same-state prioritization (n=197)
  • Comp margins: P25=-10.6% / P50=2.6% / P75=12.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.